Synergy between probiotic Lactobacillus casei and milk to maintain barrier integrity of intestinal epithelial cells.

Synergy between probiotic Lactobacillus casei and milk to maintain barrier integrity of intestinal epithelial cells.

April 03, 2019 0 Comments

We hypothesized that Lactobacillus casei BL23 and milk work synergistically to prevent damage to epithelial barrier integrity induced by pro-inflammatory cytokines. To test this, barrier disruption was induced in polarized Caco-2 monolayers by sequential, basolateral treatment with IFN-γ and TNF-α. Apical application of either 25% v/v reconstituted skim milk (RSM) or Ultra High Temperature (UHT) milk (2% fat) prior to cytokine exposure reduced losses to transepithelial electrical resistance (TER). Permeability to fluorescein isothiocyanate-dextran (FD-4; 4 kDa) was also significantly reduced in the presence of 25% v/v UHT milk (P<0.05), but not RSM. Protection against increases in paracellular permeability was even greater when cell-free preparations of L. casei BL23 fermented UHT milk or fermented RSM were applied. The permeability coefficients of cells incubated with BL23 fermented UHT milk were equivalent to the untreated controls (P = 0.12) and those cells also produced 247.6± 35.5 pg/mL IL-8, which were significantly lower than found for cytokine-treated controls (353.9 ± 40.0 pg/mL). The benefits of the fermented milk were also confirmed by the reduced expression of TNF receptor 2 (TNFR2), myosin light-chain kinase (MLCK), and claudin-encoding genes relative to thecontrols. By comparison, apical application of viable L. casei onto the Caco-2 cells did not result in protection from the barrier-disruptive actions of IFN-γ and TNF-α. These results indicate that milk can maintain intestinal barrier integrity during pro-inflammatory cytokine exposure and that this is enhanced by modifications to milk matrix caused by prior incubation with L. casei BL23. This website is for information purposes only.By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition.Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional. © Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.



Also in Industry News

Hirschsprung's Disease Genetic Analysis Reveals Mix of Common, Rare Risk Variants
Hirschsprung's Disease Genetic Analysis Reveals Mix of Common, Rare Risk Variants

May 24, 2019 0 Comments

NEW YORK (GenomeWeb) – Genetic factors that contribute to a highly heritable developmental condition called Hirschsprung's disease include a complex suite of risk variants, ranging from common polymorphisms in non-coding elements to rarer coding variants and copy number variants (CNVs), according to new research from investigators at Johns Hopkins University, the University of Washington, the Broad Institute, and New York University. "In our study, we found that the risk of the complex phenotype...

Read More

Correction to: Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage
Correction to: Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage

May 24, 2019 0 Comments

In the publication of this article [1], there is an error in one of the contributing author names. The error: ‘Jalal Abdolali Zade’ Should instead read: ‘Jalal Abdolalizadeh’ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, prov...

Read More

Protein Expression: basic concepts to new directions
Protein Expression: basic concepts to new directions

May 24, 2019 0 Comments

Date: Tuesday, 11 June, 2019 Time: 09:30  – 13:00 Place: Fèlix Serratosa,  Parc Cientific de Barcelona (PCB) This short workshop will describe many aspects of heterologous expression in E.coli, from choice of construct design through to methods to improve the levels of soluble expression and options for co-expression. In addition, it will also address expression in eukaryotic hosts, including secreted proteins and ECDs, and options for co-expression. The workshop will finish with a discussion an...

Read More